Novartis CEO Narasimhan raids GlaxoSmithKline offices for his new Sandoz chief
Novartis’ Vas Narasimhan has his new Sandoz chief.
The pharma giant reported with its Q1 numbers that they’ve raided GlaxoSmithKline’s senior executive crew for a new CEO to run the company. And they’re bringing back someone who knows the operation well.
Richard Saynor is making the leap from his last post as SVP classic & established products, commercial & digital platforms at a time speculation about the future of Sandoz has been rampant. But he may have some ideas on what can be done better. According to his LinkedIn page, he’s been at GSK for close to 9 years — after jumping over from Sandoz.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.